Hyperglycosylated hCG (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease
AssigneeUniversity of New Mexico
InventorLaurence A. Cole
Life of this patent
Estimating the term…
Abstract
The invention provides methods for detecting the presence or absence of invasive trophoblast cells. In addition, the invention provides methods for distinguishing quiescent trophoblast diseases from invasive trophoblast diseases and methods for monitoring progression of quiescent trophoblast diseases. The invention provides methods for detecting the presence or absence of germ cell tumors.
Claims45
A method of detecting the presence or absence of invasive trophoblast cells in a biological sample comprising the steps of:
- a. obtaining a biological sample from a patient;
- b. measuring an amount of hCG in the biological sample;
- c. measuring an amount of ITA in the biological sample;
- and
- d. determining the percentage of hCG that is ITA, wherein invasive trophoblast cells are detected if the percentage is 30% or greater.
A method of detecting the presence or absence of invasive trophoblast cells in a biological sample comprising the steps of:
- a. obtaining a biological sample from a patient;
- and
- b. measuring an amount of ITA in the biological sample;
- wherein invasive trophoblast cells are detected if the amount of ITA in the biological sample is 2 IU/L or greater.
A method of monitoring the progression of quiescent gestational trophoblastic disease comprising the steps of:
- a. obtaining a biological sample from a patient diagnosed as having quiescent gestational trophoblastic disease;
- b. measuring an amount of hCG in the biological sample;
- c. repeating steps (a) and (b) with a biological sample obtained at subsequent time points;
- d. measuring an amount of ITA in a biological sample from step (c) if the amount of hCG in a biological sample from step (c) is higher than the amount of hCG in step (b);
- and
- e. determining the percentage of hCG that is ITA in the biological sample from step (d).
A method of detecting the presence or absence of a germ cell tumor in a biological sample comprising the steps of:
- a. obtaining a biological sample from a patient;
- b. measuring an amount of hCG in the biological sample;
- c. measuring an amount of ITA in the biological sample;
- and
- d. determining the percentage of hCG that is ITA, wherein a germ cell tumor is detected if the percentage is 30% or greater.
A method of detecting the presence or absence of a germ cell tumor in a biological sample comprising the steps of:
- a. obtaining a biological sample from a patient;
- and
- b. measuring an amount of ITA in the biological sample;
- wherein a germ cell tumor is detected if the amount of ITA in the biological sample is 2 IU/L or greater.
A method of monitoring the progression of a germ cell tumor comprising the steps of:
- a. obtaining a biological sample from a patient diagnosed as having a germ cell tumor;
- b. measuring an amount of hCG in the biological sample;
- c. repeating steps (a) and (b) with a biological sample obtained at subsequent time points;
- d. measuring an amount of ITA in a biological sample from step (c) if the amount of hCG in a biological sample from step (c) is higher than the amount of hCG in step (b);
- and
- e. determining the percentage of hCG that is ITA in the biological sample from step (d).
Dependencies are inferred from the claim text.